Clinical trial
Prospective Registry of Exposure to Gepotidacin (PREG): a Prospective Registry of Women and Their Offspring Exposed to Gepotidacin During Pregnancy
NCT07850141 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Registry of Exposure to Gepotidacin (PREG): a Prospective Registry of Women and Their Offspring Exposed to Gepotidacin During Pregnancy
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- August 19, 2032
- Enrollment
- 614 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.